FN2 Earnings Intelligence
CVS Health Corp. income statement (quarterly)
CVS Health Corp. (CVS) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $6,875 | $10,076 | $11,787 | $9,098 | $9,542 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $95,428 | $94,588 | $98,915 | $102,871 | $100,426 | $100,088.6 | $103,199.5 |
| % Growth | - | - | - | - | - | 1.2% | 0.3% |
| Gross Profit | $42,480 | $43,531 | $44,910 | $45,826 | $44,982 | - | - |
| % Margin | 44.5% | 46.0% | 45.4% | 44.5% | 44.8% | - | - |
| EBITDA | - | $4,528 | $3,552 | -$2,073 | $5,795 | - | - |
| % Margin | - | 4.8% | 3.6% | -2.0% | 5.8% | - | - |
| Net Income | $87 | $1,779 | $1,021 | -$3,975 | $2,943 | - | - |
| % Margin | 0.1% | 1.9% | 1.0% | -3.9% | 2.9% | - | - |
| Diluted EPS | $0.07 | $1.41 | $0.80 | -$3.13 | $2.30 | $1.85 | $1.71 |
| % Growth | - | - | - | - | - | 131.1% | 154.6% |
| Operating Cash Flow | - | $4,556 | - | - | $4,249 | - | - |
| CapEx | - | $743 | - | - | $849 | - | - |
| Free Cash Flow | - | $3,813 | - | - | $3,400 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $95,428 | $94,588 | $98,915 | $102,871 | $100,426 | $100,088.6 | $103,199.5 |
| Gross Profit | $42,480 | $43,531 | $44,910 | $45,826 | $44,982 | - | - |
| EBITDA | - | $4,528 | $3,552 | -$2,073 | $5,795 | - | - |
| Net Income | $87 | $1,779 | $1,021 | -$3,975 | $2,943 | - | - |
| Diluted EPS | $0.07 | $1.41 | $0.80 | -$3.13 | $2.30 | $1.85 | $1.71 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $6,875 | $10,076 | $11,787 | $9,098 | $9,542 |
| Short-term Debt | $800 | $1,259 | $3,040 | $1,247 | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $4,556 | - | - | $4,249 |
| Capital Expenditure | - | $743 | - | - | $849 |
| Free Cash Flow | - | $3,813 | - | - | $3,400 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 44.5% | 46.0% | 45.4% | 44.5% | 44.8% |
| EBITDA Margin | - | 4.8% | 3.6% | -2.0% | 5.8% |
| Net Margin | 0.1% | 1.9% | 1.0% | -3.9% | 2.9% |
| FCF Margin | - | 4.0% | - | - | 3.4% |
| Diluted EPS Growth | - | - | - | - | - |